Replies to post #138458 on NanoViricides Inc. (NNVC)

[arvitar]

" However, management believes that the available funds are insufficient for the Company’s projected work, which is beyond normal pre-clinical development operations, leading towards an Investigational New Drug Application (IND) filing with the U.S. Food and Drug Administration (FDA), to continue through February 2019.

p.40 https://ih.advfn.com/p.php?pid=nmona&article=76757691";

^ Even the company says it doesn't have enough money to do its "projected work", which includes the work "leading towards an" IND.

Do folks not believe this?

[JG36]

I suspect that if NNVC could actually get some financing they'd be happy to diddle around for a few more years developing drugs that never get tested. But NNVC is running out of cash with little prospect of getting any financing. So I suspect Dr. Diwan's "Plan B" is now in operation -- collect that 30% nut for Theracour for as many more months as possible, then, when NNVC can no longer make its payments to Theracour the licenses become moot and Theracour owns all IP with no obligations to any licensee. NNVC is then worthless, and is bankrupt in practice whether or not formally, and the plant in Shelton, specialized to manufacturing nanoviricides which only Theracour has a legal right to do, is then worth a lot less than was paid for it. Theracour could then buy it at 40 cents to the dollar. Then Diwan owns everything, with a bit of cash still in Theracour's coffers, so could continue to diddle along with his 'cides if that's what he wants to do. If anything ever comes of them, NNVC's shareholders will have funded it but will get nothing.